Adjunctive phage therapy improves antibiotic treatment of Ventilator-Associated-Pneumonia with Pseudomonas aeruginosa

Chantal Weissfuss(Humboldt-Universität zu Berlin), Geraldine Nouailles(Humboldt-Universität zu Berlin), Ulrike Behrendt(Humboldt-Universität zu Berlin), Magdalena Bürkle(Humboldt-Universität zu Berlin), Baptiste Gaborieau(Centre National de la Recherche Scientifique), Laurent Debarbieux(Institut Pasteur), Christine H. Rohde(Leibniz Institute DSMZ – German Collection of Microorganisms and Cell Cultures), Imke H. E. Korf(Fraunhofer Institute for Toxicology and Experimental Medicine), Karen Hoffmann(Center of Advanced European Studies and Research), Gopinath Krishnamoorthy(Humboldt-Universität zu Berlin), Martin Witzenrath(Charité - Universitätsmedizin Berlin), Matthias Felten(Humboldt-Universität zu Berlin), Jingjing Li(University of Pennsylvania), Jean-Damien Ricard(Inserm)
Research Square
September 26, 2024
10.21203/rs.3.rs-5017709/v1
Cited by 1

Related Papers

Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage
|Science|2020|382
Effect of Postextubation High-Flow Nasal Oxygen With Noninvasive Ventilation vs High-Flow Nasal Oxygen Alone on Reintubation Among Patients at High Risk of Extubation Failure
|JAMA|2019|350
The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?
|Pharmaceutical Research|2010|298
Prediction of strain level phage–host interactions across the Escherichia genus using only genomic information
|Nature Microbiology|2024|119
Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19
|Nature Communications|2021|101